SCHEMBL1710484

SCHEMBL1710484

[2H]C1([2H])C([2H])([2H])C([2H])([2H])C([2H])(CSc2cccc(C(O)CCN)c2)C([2H])([2H])C1([2H])[2H]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1727499 0.85 LTB4R (0.32)
SCHEMBL1710669 0.82 CTSK (0.31)
SCHEMBL3387017 0.79 MALT1 (0.34)
SCHEMBL1710712 0.78 AR (0.34)
SCHEMBL1710639 0.77 AR (0.34)
SCHEMBL1710557 0.77 AR (0.34)
Emixustat SCHEMBL2150580 0.76 AOC3 (0.35)
SCHEMBL15946047 0.76
SCHEMBL16031371 0.75 PDE4D (0.37)
SCHEMBL3388594 0.75 APEX1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344451-A2 SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2011-07-20 EP disclosed
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-04-15 US disclosed
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-04-15 US disclosed
WO-2010028088-A2 SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-03-11 WO disclosed